tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Dominic Lunn, 7 are a HOLD (53.85%), 3 are a SELL (23.08%), 3 are a BUY (23.08%).
Analyst Dominic Lunn, currently employed at CREDIT SUISSE, carries an average stock price target met ratio of 40% that have a potential upside of 6.22% achieved within 65 days.
Dominic Lunn’s has documented 25 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 03-Nov-2022.
Analyst best performing recommendations are on NVO (NOVO NORDISK A/S).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 8/23/2021. The price target of $49.37 was fulfilled within 1 day with a profit of $0.22 (0.44%) receiving and performance score of 4.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$41
$-2.35 (-5.42%)
10 months 9 days ago
(01-Dec-2024)
1/1 (100%)
$7.82 (23.57%)
182
Buy
1 years 2 months 10 days ago
(31-Jul-2024)
0/13 (0%)
$-16.49 (-43.22%)
Buy
$45
$1.65 (3.81%)
$47
1 years 2 months 25 days ago
(15-Jul-2024)
2/3 (66.67%)
$8.15 (22.12%)
976
Buy
$19.52
1 years 7 months 28 days ago
(12-Feb-2024)
0/3 (0%)
$-12.79 (-39.59%)
Buy
$48
$4.65 (10.73%)
$39
1 years 9 months 8 days ago
(02-Jan-2024)
3/4 (75%)
$11.79 (32.56%)
323
What Year was the first public recommendation made by Dominic Lunn?
